De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

UG Healthcare Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Keck Keong Lee

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	8yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	4.6yrs
Gemiddelde ambtstermijn bestuur	9.9yrs

Recente managementupdates

Recent updates

CEO

Keck Keong Lee (70 yo)

8yrs

Tenure

Mr. Keck Keong Lee has been the Chief Executive Officer at UG Healthcare Corporation Limited since October 19, 2016 and its Executive Director since November 20, 2014 and served as its Non-Executive Direct...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Keck Keong Lee	CEO & Executive Director	8yrs	geen gegevens	geen gegevens
Jun Yih Lee	Finance Director & Executive Director	5.2yrs	geen gegevens	0.46% SGD 369.9k
Jun Linn Lee	COO & Executive Director	4yrs	geen gegevens	0.36% SGD 288.2k
See Wong	Executive Director	no data	geen gegevens	4.71% SGD 3.8m
Pek Wee Wong	Head of Manufacturing	no data	geen gegevens	geen gegevens
Mei Low	Company Secretary	3.3yrs	geen gegevens	geen gegevens

4.6yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 8K7 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Keck Keong Lee	CEO & Executive Director	9.9yrs	geen gegevens	geen gegevens
Jun Yih Lee	Finance Director & Executive Director	9.9yrs	geen gegevens	0.46% SGD 369.9k
Jun Linn Lee	COO & Executive Director	9.9yrs	geen gegevens	0.36% SGD 288.2k
See Wong	Executive Director	9.9yrs	geen gegevens	4.71% SGD 3.8m
Lip Chi Ng	Independent Non-Executive Director	9.9yrs	geen gegevens	geen gegevens
Wah Pung Yip	Non-Executive Independent Chairman	9.9yrs	geen gegevens	geen gegevens
Lee Eng Ng	Independent Non-Executive Director	less than a year	geen gegevens	geen gegevens

9.9yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 8K7 wordt beschouwd als ervaren (gemiddelde ambtstermijn 9.9 jaar).

UG Healthcare Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

UG Healthcare Corporation Limited Announces Appointment of Ng Lee Eng as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

UG Healthcare Corporation Limited Announces Cessation Vincent Leow as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

UG Healthcare Corporation Limited, Annual General Meeting, Oct 30, 2023

Less than half of directors are independent

UG Healthcare Corporation Limited, Annual General Meeting, Oct 28, 2022

Less than half of directors are independent

Recent updates

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

UG Healthcare Corporation Limited (Catalist:8K7) completed the acquisition of 50% stake in UG NITREX, S. L. from Afaprot, S. L. and Martínez for €0.5 million.

First half 2024 earnings released: S$0.008 loss per share (vs S$0.008 loss in 1H 2023)

New major risk - Revenue and earnings growth

UG Healthcare Corporation Limited to Report First Half, 2024 Results on Feb 13, 2024

UG Healthcare Corporation Limited Announces Appointment of Ng Lee Eng as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

New minor risk - Share price stability

UG Healthcare Corporation Limited Announces Cessation Vincent Leow as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

Full year 2023 earnings released: S$0.033 loss per share (vs S$0.059 profit in FY 2022)

UG Healthcare Corporation Limited, Annual General Meeting, Oct 30, 2023

Full year 2023 earnings released: S$0.033 loss per share (vs S$0.059 profit in FY 2022)

New minor risk - Financial data availability

First half 2023 earnings released: S$0.008 loss per share (vs S$0.034 profit in 1H 2022)

UG Healthcare Corporation Limited to Report First Half, 2023 Results on Feb 14, 2023

Less than half of directors are independent

UG Healthcare Corporation Limited Approves Special Cash Dividend for the Financial Year Ended 30 June 2022, Payable on 16 December 2022

UG Healthcare Corporation Limited (Catalist:8K7) entered into a share sale agreement to acquire Indigo Teguh Sdn Bhd from Lee Keck Keong for MYR 100.

Full year 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited, Annual General Meeting, Oct 28, 2022

Consensus revenue estimates fall by 12%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited Recommends Tax Exempt Special Dividend for Fiscal Year 2022

Less than half of directors are independent

Now 20% undervalued after recent price drop

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited to Report First Half, 2022 Results on Feb 11, 2022

UG Healthcare Corporation Limited to Report First Half, 2022 Results on Feb 11, 2022

Price target decreased to S$0.44

Full year 2021 earnings released: EPS S$0.19 (vs S$0.023 in FY 2020)

Price target decreased to S$0.55

Less than half of directors are independent

UG Healthcare Corporation Limited Provides Update on Covid-19 Situation in the Group's Manufacturing Division in Malaysia

Company Secretary Kar Yeoh has left the company

Third quarter 2021 earnings released: EPS S$0.056 (vs S$0.011 in 3Q 2020)

Price target decreased to S$0.99

Second quarter 2021 earnings released

UG Healthcare Corporation Limited to Report First Half, 2021 Results on Feb 04, 2021

New 90-day low: S$0.36

New 90-day low: S$0.23

New 90-day low: S$0.60

New 90-day low: S$0.64

First quarter 2021 earnings released: EPS S$0.039

Analysts update estimates

Annual earnings released: Revenue and earnings beat expectations

Full year earnings released - EPS S$0.023

Analysts increase revenue estimates to S$240.3m

UG Healthcare Corporation Limited has completed a Follow-on Equity Offering in the amount of SGD 19.0875 million.

Analysts increase revenue estimates to S$180.9m

Full year earnings released - EPS S$0.068

New 90-day high - S$2.91

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd